Multichannel
Sales and Marketing/ Views & Analysis/ Views and analysis
What is modular content and why do pharma marketers need it NOW?
mike.hammerton@pharmaphorum.com
digital content, digital marketing, Modular content, Multichannel, omnichannel, pharma marketing, Tag
0 Comment
Sales and Marketing/ Views & Analysis/ Views and analysis
Designing HCP engagement for the next normal
mike.hammerton@pharmaphorum.com
customer experience, HCP engagement, IQVIA, Multichannel, omnichannel, Sales reps
0 Comment
Sales and Marketing/ Views & Analysis/ Views and analysis
Time to change the channel? The future for customer engagement models
mike.hammerton@pharmaphorum.com
commercial strategy, COVID-19, customer engagement, Multichannel, omnichannel, Sarah Rickwood
0 Comment
Pharma to increase spend on digital marketing – report
Richard Staines
digital marketing, marketing, Multichannel
0 Comment
Digital/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis
A pharma guide to digital health, multichannel and digital transformation
Digital/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis
Adapting pharma marketing for the evolving consumer journey
mike.hammerton@pharmaphorum.com
comms, marketing, Multichannel, Tag, webinar
0 Comment
Deep Dive/ Oncology/ Views & Analysis
Smarter thinking about pharmaceutical marketing
mike.hammerton@pharmaphorum.com
Deep Dive: Oncology and ASCO 2019, marketing, Multichannel, patient, Robb DeFilippis, Tag
0 Comment
Market Access/ R&D/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis
Nine for 2019: Opportunities for pharma
mike.hammerton@pharmaphorum.com
2019, biosimilars, China, gene therapies, industry, Multichannel, NIne for 2019, real world data, RWE
0 Comment